XBIT XBiotech Inc. - Common Stock
$2,26
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 13, 2026
Rango 52S
$2–$4
11% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
—
P/E (TTM)
-1.6
ROE
—
Margen de Beneficio Neto
—
XBIT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.26
Capitalización Bursátil
—
P/E (TTM)
-1.6
BPA (TTM)
$-1.49
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$2 – $4
XBIT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2018-12-31
→
2023-12-31
BPA
$-1.49
2017-12-31
→
2025-12-31
Flujo de caja libre
—
2016-12-31
→
2022-12-31
Márgenes
—
2020-12-31
→
2022-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
XBIT
Mediana de Pares
P/E (TTM)
-1.6
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
XBIT
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
XBIT
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
XBIT
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
XBIT
Mediana de Pares
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Rendimiento por Dividendo
—
Ratio de Pago
—
CAGR de Dividendos a 5 años
—
| Fecha ex-dividendo | Monto |
|---|---|
| 15 de julio de 2021 | $2,5000 |
XBIT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
3.7%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2020 | $0.00 | $0.06 | -0.06% |
| 31 de diciembre de 2019 | $14.59 | $-0.15 | 14.7% |
| 30 de septiembre de 2019 | $-0.15 | $-0.15 | 0.00% |
| 30 de junio de 2019 | $-0.16 | $-0.15 | -0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| XBIT | — | -1.6 | — | — | — | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| NMAD | — | — | — | — | — | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| RNTX | — | -0.6 | — | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $4M | $18M | $44M | $0 | $0 | |
| Cost of Revenue | · | · | $0 | $651.0K | $6M | $35M | $0 | $0 | |
| Gross Profit | · | · | $0 | $3M | $13M | $9M | $0 | $0 | |
| R&D Expense | $47M | $38M | $33M | $32M | $28M | $10M | $24M | $16M | |
| SG&A Expense | $8M | $5M | $5M | $6M | $9M | $18M | $7M | $5M | |
| Operating Expenses | · | $42M | $38M | $38M | $38M | $28M | $31M | $21M | |
| Operating Income | $-56M | $-42M | $-38M | $-34M | $-25M | $-18M | $-31M | $-21M | |
| Other Non-op | $1M | $432.0K | $883.0K | $-121.0K | $-132.0K | $-503.0K | $10.0K | $4.0K | |
| Pretax Income | $-45M | $-39M | $-24M | $-34M | $-25M | $-13M | $718M | $-21M | |
| Income Tax | $235.0K | $-32.0K | $244.0K | $-688.0K | $-8M | $-2M | $50M | $0 | |
| Net Income | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| EPS (Basic) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $17.17 | $-0.59 | |
| EPS (Diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 | |
| Shares (Basic) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 38,945,468 | 35,804,304 | |
| Shares (Diluted) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 46,319,457 | 35,804,304 | |
| EBITDA | · | · | · | $-34M | $-25M | $-18M | $-31M | $-21M |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $173M | $200M | $157M | $237M | $237M | $715M | $16M | |
| Short-term Investments | · | · | $0 | $60M | $0 | · | · | · | |
| Receivables | · | $700.0K | $860.0K | $1M | $0 | $4M | $0 | · | |
| Prepaid Expense | $1M | $1M | $760.0K | $601.0K | $934.0K | $582.0K | $2M | $1M | |
| Current Assets | $127M | $175M | $202M | $220M | $247M | $326M | $716M | $17M | |
| PP&E (Net) | $23M | $25M | $25M | $26M | $28M | $27M | $25M | $27M | |
| Accum. Depreciation | · | $22M | $20M | $16M | $16M | $13M | $12M | $9M | |
| Total Assets | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Accounts Payable | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $6M | $3M | $4M | $2M | $1M | $1M | $4M | $1M | |
| Current Liabilities | $8M | $15M | $6M | $4M | $3M | $4M | $60M | $3M | |
| Deferred Tax | $5.0K | $0 | $0 | $59.0K | $873.0K | $0 | · | · | |
| Total Liabilities | $10M | $17M | $8M | $6M | $6M | $5M | $61M | $3M | |
| Common Stock | $277M | $273M | $271M | $267M | $262M | $250M | $325M | $279M | |
| Retained Earnings | $-136M | $-91M | $-52M | $-28M | $5M | $98M | $431M | $-238M | |
| AOCI | · | · | $0 | $826.0K | $2M | $1M | $-106.0K | $-255.0K | |
| Stockholders' Equity | $140M | $182M | $219M | $240M | $269M | $349M | $756M | $41M | |
| Liabilities + Equity | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,436,964 | 30,439,275 | 30,439,275 | 29,304,396 | 41,519,633 | 35,899,772 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $3M | $5M | $4M | $13M | $3M | $2M | |
| Deferred Tax | $5.0K | $0 | $-59.0K | $-816.0K | $1M | $-47.0K | $-13.0K | $0 | |
| Operating Cash Flow | $-40M | $-31M | $-19M | $-15M | $69M | $-65M | $-18M | $-17M | |
| CapEx | $289.0K | $1M | $362.0K | $585.0K | $4M | $4M | $204.0K | $122.0K | |
| Investing Cash Flow | $-289.0K | $-1M | $61M | $-64M | $-4M | $-4M | $675M | $-122.0K | |
| Stock Issued | · | · | $4.8K | · | $8M | $10M | $4M | · | |
| Stock Repurchased | · | $0 | $14.0K | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $8M | $10M | $4M | · | |
| Dividends Paid | · | · | · | $0 | $75M | $0 | $0 | · | |
| Financing Cash Flow | $-10M | $10M | $-9.0K | $0 | $-67M | $-410M | $42M | $201.0K | |
| Net Change in Cash | $-47M | $-27M | $43M | $-80M | $-383.0K | $-477M | $699M | $-16M | |
| Taxes Paid | $-81.0K | $87.0K | $141.0K | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-15M | $66M | $-69M | $-18M | $-17M |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 83.8% | 68.4% | 21.5% | · | · | |
| Operating Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| Net Margin | · | · | · | -820.4% | -94.7% | -25.5% | · | · | |
| Pretax Margin | · | · | · | -837.6% | -138.4% | -29.1% | · | · | |
| EBITDA Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| ROA | · | · | · | -12.6% | -5.5% | -1.9% | 155.3% | -39.4% | |
| ROE | · | · | · | -13.6% | -6.4% | -3.2% | 163.0% | -47.9% | |
| ROIC | · | · | · | -14.1% | -6.4% | -4.6% | -3.9% | -50.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 54.1 | 71.5 | 81.8 | 11.9 | 5.8 | |
| Quick Ratio | · | · | · | 53.5 | 68.6 | 60.6 | 11.9 | 5.4 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | · | · | · | · | 8.9 | 21.4 | · | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -78.2% | -58.2% | · | · | · |
Valoración (TTM) 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $4M | $18M | $44M | $0 | $0 | |
| Net Income TTM | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| Market Cap | · | · | · | $107M | $339M | $459M | $775M | $182M | |
| P/E | -1.6 | -3.1 | -4.9 | -3.2 | -19.2 | -43.5 | 1.3 | -8.6 | |
| P/S | · | · | · | 26.6 | 18.4 | 10.4 | · | · | |
| P/B | · | · | · | 0.4 | 1.3 | 1.3 | 1.0 | 4.4 | |
| P / Tangible Book | 0.5 | 0.7 | 0.6 | 0.4 | 1.3 | 1.3 | · | · | |
| P / Cash Flow | · | · | · | -7.2 | 4.9 | -7.0 | -42.4 | -11.0 | |
| P / FCF | · | · | · | -6.9 | 5.1 | -6.7 | -41.9 | -10.9 | |
| Dividend Yield | · | · | · | 0.00% | 22.1% | 0.00% | 0.00% | · | |
| Earnings Yield | -62.3% | -31.9% | -20.2% | -30.8% | -5.2% | -2.3% | 77.4% | -11.6% | |
| Payout Ratio | · | · | · | 0.00% | -430.7% | · | · | · | |
| Annual Payout | · | · | · | $0 | $75M | $0 | $0 | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $300.0K | $2M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $16.0K | $215.0K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $284.0K | $1M | |
| R&D Expense | $5M | $5M | $25M | $5M | $5M | $12M | $8M | $7M | $13M | $10M | $8M | $8M | $11M | $6M | $7M | $7M | |
| SG&A Expense | $850.0K | $1M | $4M | $967.0K | $1M | $2M | $927.0K | $777.0K | $2M | $1M | $782.0K | $973.0K | $2M | $915.0K | $1M | $840.0K | |
| Operating Expenses | $6M | · | · | $6M | $6M | $14M | $9M | $8M | $15M | $11M | $9M | $9M | $13M | $7M | $8M | $8M | |
| Operating Income | $-6M | $-6M | $-30M | $-6M | $-6M | $-14M | $-9M | $-8M | $-15M | $-11M | $-9M | $-9M | $-13M | $-7M | $-8M | $-6M | |
| Other Non-op | $-9.0K | $1M | $549.0K | $-85.0K | $-3.0K | $995.0K | $407.0K | $25.0K | $0 | $0 | $3.0K | $0 | $750.0K | $130.0K | $-2.0K | $0 | |
| Pretax Income | $-7M | $-5M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-10M | |
| Income Tax | $46.0K | $49.0K | $76.0K | $102.0K | $28.0K | $29.0K | $-41.0K | $9.0K | $-25.0K | $25.0K | $-172.0K | $308.0K | $71.0K | $37.0K | $578.0K | $2M | |
| Net Income | $-7M | $-6M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-13M | |
| EPS (Basic) | $-0.22 | $-0.18 | $-0.87 | $-0.20 | $-0.06 | $-0.36 | $-0.34 | $-0.16 | $-0.43 | $-0.33 | $-0.15 | $-0.24 | $-0.29 | $-0.13 | $-0.10 | $-0.42 | |
| Shares (Basic) | 30,487,731 | 30,487,731 | -60,975,462 | 30,487,731 | 30,487,731 | 30,487,731 | -60,911,651 | 30,472,557 | 30,456,101 | 30,443,973 | -60,876,572 | 30,436,638 | 30,439,118 | 30,439,275 | -60,878,554 | 30,439,277 | |
| EBITDA | $-6M | $-6M | · | $-6M | $-6M | $-14M | · | $-8M | $-15M | $-11M | · | $-9M | $-13M | $-7M | · | $-6M |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $115M | $126M | $147M | $153M | $156M | $173M | $183M | $189M | $201M | $200M | $202M | $143M | $152M | $157M | $161M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $61M | $60M | $60M | $60M | |
| Receivables | · | · | · | $450.0K | $480.0K | $480.0K | · | $730.0K | $870.0K | $870.0K | · | $881.0K | · | · | · | $2M | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $760.0K | $879.0K | $947.0K | $703.0K | $601.0K | $621.0K | |
| Current Assets | $111M | $117M | $127M | $149M | $155M | $158M | $175M | $185M | $191M | $203M | $202M | $204M | $210M | $216M | $220M | $223M | |
| PP&E (Net) | $22M | $23M | $23M | $23M | $24M | $24M | $25M | $25M | $25M | $25M | $25M | $25M | $26M | $26M | $26M | $27M | |
| Accum. Depreciation | · | · | · | · | · | · | $22M | · | · | · | $18M | · | · | · | $16M | · | |
| Total Assets | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Accounts Payable | $1M | $857.0K | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $1M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $2M | $2M | $6M | $2M | $2M | $4M | $3M | $4M | $5M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Current Liabilities | $3M | $3M | $8M | $4M | $4M | $5M | $15M | $16M | $17M | $17M | $6M | $5M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $5.0K | $5.0K | $5.0K | · | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $59.0K | $872.0K | |
| Total Liabilities | $5M | $5M | $10M | $5M | $6M | $7M | $17M | $18M | $19M | $19M | $8M | $7M | $6M | $5M | $6M | $6M | |
| Common Stock | $277M | $277M | $277M | $277M | $277M | $276M | $273M | $272M | $272M | $272M | $271M | $270M | $269M | $268M | $267M | $266M | |
| Retained Earnings | $-149M | $-142M | $-136M | $-109M | $-103M | $-102M | $-91M | $-80M | $-75M | $-62M | $-52M | $-48M | $-40M | $-32M | $-28M | $-25M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $440.0K | $440.0K | $440.0K | $826.0K | $3M | |
| Stockholders' Equity | $128M | $135M | $140M | $167M | $173M | $175M | $182M | $192M | $197M | $209M | $219M | $223M | $229M | $237M | $240M | $245M | |
| Liabilities + Equity | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,479,406 | 30,463,156 | 30,450,881 | 30,436,964 | 30,436,964 | 30,435,714 | 30,439,275 | 30,439,275 | 30,439,277 |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $172.0K | $172.0K | $162.0K | $24.0K | $107.0K | $3M | $628.0K | $365.0K | $379.0K | $381.0K | $688.0K | $955.0K | $914.0K | $705.0K | $1M | $1M | |
| Operating Cash Flow | $-5M | $-9M | $-23M | $-4M | $-6M | $-7M | $-7M | $-6M | $-11M | $-7M | $-3M | $-1M | $-9M | $-5M | $-3M | $-160.0K | |
| CapEx | $0 | $0 | $34.0K | $110.0K | $51.0K | $94.0K | $84.0K | $338.0K | $627.0K | $255.0K | $115.0K | $33.0K | $208.0K | $6.0K | $132.0K | $210.0K | |
| Investing Cash Flow | $-4.0K | $9.0K | $-34.0K | $-110.0K | $-51.0K | $-94.0K | $-84.0K | $-338.0K | $-627.0K | $-255.0K | $-115.0K | $62M | $-208.0K | $-6.0K | $-4M | $-60M | |
| Stock Issued | · | · | · | · | · | · | · | $64.0K | $48.0K | $55.0K | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $55.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 | $-10M | $283.0K | $64.0K | $48.0K | $10M | $0 | $5.0K | $-14.0K | $0 | $0 | $0 | |
| Net Change in Cash | $-6M | $-10M | $-22M | $-6M | $-3M | $-17M | $-10M | $-5M | $-13M | $1M | $-2M | $59M | $-9M | $-5M | $-3M | $-65M | |
| Free Cash Flow | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 87.2% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -753.5% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -610.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| ROA | -4.3% | -3.4% | · | -3.1% | -0.89% | -5.3% | · | -2.3% | -5.8% | -4.3% | · | -3.1% | -3.5% | -1.5% | · | -4.8% | |
| ROE | -4.5% | -3.5% | · | -3.4% | -0.95% | -5.7% | · | -2.4% | -6.1% | -4.5% | · | -3.1% | -3.6% | -1.5% | · | -4.9% | |
| ROIC | -4.8% | -4.7% | · | -3.7% | -3.7% | -7.8% | · | -4.1% | -7.6% | -5.2% | · | -4.0% | -5.8% | -3.0% | · | -3.2% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.2 | 39.0 | · | 41.8 | 40.2 | 29.1 | · | 11.6 | 11.1 | 12.0 | · | 38.6 | 47.1 | 59.8 | · | 62.4 | |
| Quick Ratio | 32.7 | 38.5 | · | 41.5 | 39.8 | 28.9 | · | 11.5 | 11.1 | 12.0 | · | 38.4 | 46.0 | 58.8 | · | 61.9 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 2.1 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $3M | $4M | · | $8M | |
| Net Income TTM | $-20M | $-24M | · | $-24M | $-31M | $-39M | · | $-33M | $-35M | $-31M | · | $-23M | $-28M | $-31M | · | $-36M | |
| Market Cap | $70M | $72M | · | $81M | $91M | $99M | · | $236M | $157M | $248M | · | $125M | $181M | $105M | · | $110M | |
| P/E | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.4 | 0.6 | · | 0.3 | 0.4 | 0.2 | · | 0.3 | |
| P/S | 41.7 | 42.6 | · | 48.3 | 53.9 | 58.8 | · | 140.2 | 93.2 | 147.4 | · | 74.6 | 56.3 | 28.3 | · | 13.4 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Cash Flow | · | -8.0 | · | · | · | -14.7 | · | · | · | -34.4 | · | · | · | -21.8 | · | · | |
| P / FCF | · | -8.0 | · | · | · | -14.5 | · | · | · | -33.2 | · | · | · | -21.8 | · | · | |
| Earnings Yield | 623.9% | 610.6% | · | 539.5% | 483.2% | 442.9% | · | 185.6% | 279.2% | 176.5% | · | 348.3% | 241.6% | 415.9% | · | 396.4% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | — | — | $0 | $4M | $18M |
| Margen Bruto % | — | — | — | 83.8% | 68.4% |
| Margen Operativo % | — | — | — | -860.1% | -136.4% |
| Beneficio neto | $-46M | $-39M | $-25M | $-33M | $-17M |
| EPS Diluido | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | — | — | — | 54.1 | 71.5 |
| Ratio Rápido | — | — | — | 53.5 | 68.6 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | — | — | $-15M | $66M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 47 declarantes · $4.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (+1 vs trimestre anterior) | 3 (-5 vs trimestre anterior) | 4 (-2 vs trimestre anterior) | 10 (-1 vs trimestre anterior) | +163K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $460 419 | 200 182 | 11,15% | Acciones |
| RBF Capital, LLC | $456 552 | 198 501 | 11,06% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $399 019 | 173 361 | 9,66% | Acciones |
| MORGAN STANLEY | $338 015 | 146 963 | 8,19% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $226 428 | 98 447 | 5,48% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $212 440 | 92 365 | 5,15% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $182 459 | 79 330 | 4,42% | Acciones |
| JANE STREET GROUP, LLC | $171 810 | 74 700 | 4,16% | Opción de compra |
| STATE STREET CORP | $167 914 | 73 006 | 4,07% | Acciones |
| Empowered Funds, LLC | $136 958 | 59 547 | 3,32% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101 200 | 44 000 | 2,45% | Opción de venta |
| Nuveen Asset Management, LLC | $98 272 | 24 879 | 2,38% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $95 825 | 41 663 | 2,32% | Acciones |
| Bank of New York Mellon Corp | $86 018 | 37 399 | 2,08% | Acciones |
| Squarepoint Ops LLC | $79 941 | 34 757 | 1,94% | Acciones |
| Qube Research & Technologies Ltd | $77 211 | 33 570 | 1,87% | Acciones |
| BlackRock, Inc. | $69 681 | 30 296 | 1,69% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68 770 | 29 900 | 1,67% | Opción de compra |
| CITADEL ADVISORS LLC | $67 142 | 29 192 | 1,63% | Acciones |
| NORTHERN TRUST CORP | $65 585 | 28 515 | 1,59% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $64 269 | 27 943 | 1,56% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $60 867 | 26 464 | 1,47% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $57 500 | 25 000 | 1,39% | Acciones |
| BANK OF AMERICA CORP /DE/ | $54 715 | 23 789 | 1,33% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $49 036 | 21 320 | 1,19% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $42 276 | 18 381 | 1,02% | Acciones |
| TWO SIGMA ADVISERS, LP | $38 957 | 16 300 | 0,94% | Acciones |
| SYNOVUS FINANCIAL CORP | $31 377 | 11 796 | 0,76% | Acciones |
| Thomasville National Bank | $30 705 | 13 350 | 0,74% | Acciones |
| XTX Topco Ltd | $30 084 | 13 080 | 0,73% | Acciones |
| Pinnacle Financial Partners, Inc. | $27 131 | 11 796 | 0,66% | Acciones |
| Point72 Asia (Singapore) Pte. Ltd. | $18 133 | 6 817 | 0,44% | Acciones |
| VANGUARD GROUP INC | $16 752 | 7 009 | 0,41% | Acciones |
| Vanguard Global Advisers, LLC | $16 121 | 7 009 | 0,39% | Acciones |
| Cubist Systematic Strategies, LLC | $14 151 | 5 320 | 0,34% | Acciones |
| UBS Group AG | $11 581 | 5 035 | 0,28% | Acciones |
| McIlrath & Eck, LLC | $1 770 | 753 | 0,04% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $862 | 370 | 0,02% | Acciones |
| JPMORGAN CHASE & CO | $224 | 96 | 0,01% | Acciones |
| BARCLAYS PLC | $216 | 94 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $85 | 37 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $71 | 30 654 | 0,00% | Acciones |
| Larson Financial Group LLC | $48 | 21 | 0,00% | Acciones |
| CWM, LLC | $31 | 13 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $25 | 11 | 0,00% | Acciones |
| JANE STREET GROUP, LLC | $2 | 1 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $0 | 74 | 0,00% | Acciones |
Informantes de la empresa 23 insiders · 10 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| John Simard | Chief Executive Officer | 17 de marzo de 2025 A | 3 823 166 | 0 | 0 | $0 |
| James Scott Whitehurst | Chief Financial Officer | 2 de mayo de 2016 A | — | 0 | 0 | $0 |
| Sushma Shivaswamy | Chief Scientific Officer | 10 de febrero de 2023 A | 0 | 0 | 0 | $0 |
| Queena Han | VP Finance & HR | 19 de noviembre de 2021 A | 57 692 | 0 | 0 | $0 |
| Benjamin Guzman | Sr.VP Corp. Strategy & Finance | 7 de julio de 2017 A | — | 0 | 0 | $0 |
| Michael Stecher | Medical Director | 19 de junio de 2017 M | — | 0 | 0 | $0 |
| Trey Benson | VP of Commercial Development | 20 de junio de 2016 A | — | 0 | 0 | $0 |
| Dawn Mccollough | VP Clinical Operations | 16 de mayo de 2016 A | — | 0 | 0 | $0 |
| Kalidip Choudhury | VP of Business Development | 14 de diciembre de 2015 M | — | 0 | 0 | $0 |
| Kelly Thornburg | SVP of Operations | 8 de junio de 2015 A | — | 0 | 0 | $0 |
| David Spencer Soffer | Consejero | 1 de octubre de 2025 A | — | 0 | 0 | $0 |
| Thomas Martin Kuendig | Consejero | 1 de octubre de 2025 A | — | 0 | 0 | $0 |
| Tevi David Troy | Consejero | 1 de octubre de 2025 A | — | 0 | 0 | $0 |
| Craig Evan Rademaker | Consejero | 1 de octubre de 2025 A | — | 0 | 0 | $0 |
| Peter Libby | Consejero | 20 de junio de 2024 A | — | 0 | 0 | $0 |
| Donald H. Macadam | Consejero | 20 de junio de 2024 A | 10 000 | 0 | 0 | $0 |
| Jan-Paul Waldin | Consejero | 20 de junio de 2024 A | 200 243 | 0 | 0 | $0 |
| Thorpe W Mckenzie | Consejero | 20 de junio de 2024 A | 2 597 471 | 0 | 0 | $0 |
| Daniel Vasella | Consejero | 19 de junio de 2017 M | — | 0 | 0 | $0 |
| Fabrizio Bonanni | Consejero | 19 de junio de 2017 M | — | 0 | 0 | $0 |
| BAY STREET FINANCIAL S.A. | Propietario del 10% | 18 de diciembre de 2020 S | 1 981 515 | 0 | 0 | $0 |
| Thomas Gut | Propietario del 10% | 12 de febrero de 2020 D | 3 914 111 | 0 | 0 | $0 |
| Fondation Rennes | Propietario del 10% | 3 de febrero de 2020 G | 110 282 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 13 228 NS | 31 de mayo de 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,00% | 4 871 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |